NHMRC Centre for Blood Transplant and Cell Therapies Webinar 21 March 2022

The Centre for Blood Transplant and Cell Therapies (CBTCT) brings together the largest allogeneic stem cell transplant units in Australia with a focus on identifying transplant and cell therapy strategies to reduce graft versus host disease and improve patient and disease outcomes after transplant. In this webinar series, speakers will review major topics in stem cell transplantation and cell therapy, highlighting how key advances are addressing the current challenges in stem cell transplantation. This webinar features Prof Stefan Ciurea, who is the Director of the UCI Health Haematopoetic Stem Cell Transplantation and Cell Therapies Program and a Professor of Clinical Medicine at the UCI School of Medicine. Prof Ciurea is the author of more than 150 peer-reviewed publications and more than 10 book chapters. He has made important research contributions in the biology of myelofibrosis and haploidentical haematopoietic stem cell transplantation, including the first documentation of the association between anti-HLA antibodies and graft rejection as well as in the development of natural killer cell based therapeutics. In this webinar, Prof Ciurea will be speaking on the utility of NK cell based therapies in improving outcomes of patients with malignancy.

Speaker:

Professor Stefan Ciurea – University of California, IRvine

When: Monday 21 March 2021, 12pm AEDT

For more information click here

Link to webinar:

https://uni-sydney.zoom.us/j/83782538124

Link to CBTCT website for all webinar recordings:

https://bloodcelltherapy.org.au/